Thymic Stromal Lymphopoietin (TSLP) in Vitiligo

Cairo University50 enrolled

Overview

study \& verify the hypothesis of the involvement of TSLP in the pathogenesis of vitiligo in comparison to their levels in the healthy control persons.

Study Type

INTERVENTIONAL

Allocation

NON_RANDOMIZED

Purpose

HEALTH_SERVICES_RESEARCH

Masking

NONE

Enrollment

Conditions

Vitiligo

Interventions

skin biopsyOTHER

Lesional skin biopsy was taken from every patient. Also a skin biopsy was taken from every control subject

Eligibility

Sex: ALLMin age: 18 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * • Patients with generalized non-segmental vitiligo. * Both sexes. * Age \< 18 years old age. * New cases or cases not receiving any medication for at least 3 months ago. Exclusion Criteria: * • Age: Patients \< 18 years. * Segmental or universal vitiligo. * Pregnant and lactating females. Autoimmune diseases

Outcomes

Primary Outcomes

Expression levels of TSLP in patients of Vitiligo.

Time frame: 7 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.